Login / Signup
Severe Autoimmune intravascular hemolytic anemia in patients receiving Alemtuzumab for Multiple sclerosis.
Parth Sharma
Annapurna Saksena
Adolfo Enrique Diaz
Yifan Pang
Parth Desai
Published in:
Blood advances (2022)
Keyphrases
</>
multiple sclerosis
chronic kidney disease
white matter
iron deficiency
coronary artery
early onset
drug induced